Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Rumors Were True: Abbott Buys St. Jude For $25b To Create Third Cardiovascular Giant

This article was originally published in Clinica

Executive Summary

Abbott Laboratories has agreed to acquire St. Jude Medical for $25bn, creating a third player, along with Boston Scientific and Medtronic, that competes in all major sectors of the cardiovascular device business.


Related Content

BD, CR Bard Merger To Create Vascular Access Device Giant
Medtechs At The Wheel In New Health Care Landscape
Abbott Becomes CRM Player Overnight By Completing St. Jude Deal
Final Countdown To St. Jude Acquisition – Abbott Scores US Antitrust Approval
Cybersecurity Allegations, Safety Alert Will Not Impact St. Jude Acquisition, Abbott Affirms
No Surprise As Abbott Cuts Loose Angio-Seal, Femoseal To Terumo
St. Jude Warns Of Battery-Depletion Issues With Some ICDs
J&J Buys Abbott's Ophthalmics Business For $4bn-Plus
Abbott, Alere Agree To Mediation For Troubled Merger
Earnings Winners And Losers: ABT, ISRG, STJ, SYK





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts